Press Announcements 2018

The pharmaceutical industry's interest to move from batch to continuous manufacturing is clearly increasing. The ECA therefore invites pharmaceutical companies as well as equipment and system suppliers to an information exchange at the Continuous Manufacturing Conference in Barcelona. On 27/28 November 2018 we'll focus on technology, process control, quality assurance and regulatory approval for the continuous manufacture of solid dosage forms. Companies like Janssen Pharmaceuticals, Pfizer, TEVA, GSK und Hovione that already gained experience with continuous processes will present their approach. Exhibitors at this conference will have the opportunity to introduce new technologies in short presentations at the conference. Please note though, that space and presentation slots are strictly limited and are subject to ECA approval. You can find the detailed programme brochure and a form for the registration of a table top stand on ECA's webpage.

The United States Pharmacopeia (USP) just announced to cancel and redevelop their previously published draft proposals on the glass general chapters. The latest developments will thus be in the centre of attention of a joint USP-Ph.Eur.-ECA conference on glass.

The ECA Pharmaceutical Microbiology Working Group completed the first chapter of their guidance on handling of microbiological deviations to support members in dealing with OOS and OOL results.

The presentations at the Joint Conference on Nano and Micro Formulations were updated regarding the current WHO and FDA considerations and recommendations.